23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › MARAVAI LIFESCIENCES HOLDINGS INC. › 2023-2024

MARAVAI LIFESCIENCES HOLDINGS INC. 2023-2024 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and MARAVAI LIFESCIENCES HOLDINGS INC.’s Form 8-K, filed May 28, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 6Ballot items
  • 232Asset managers, any item
  • 1,514Fund votes
  • May 23, 2024Meeting date

Results at a glance

Meeting of May 23, 2024: 6 items on MARAVAI LIFESCIENCES HOLDINGS INC.’s Form 8-K, filed May 28, 2024: 4 elected · 2 approved.

Dissent

Notable dissent: 4 directors (15.8%, 14.8%, 14.8%, 13.8% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore MARAVAI LIFESCIENCES HOLDINGS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by MARAVAI LIFESCIENCES HOLDINGS INC.

These tallies are MARAVAI LIFESCIENCES HOLDINGS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 28, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

MARAVAI LIFESCIENCES HOLDINGS INC. — official shareholder meeting results, meeting held May 23, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Benjamin Daverman 193,739,240---- 33,663,9409,528,759 85%Elected—
Elect Director: Susannah Gray 193,773,793---- 33,629,3879,528,759 85%Elected—
Elect Director: Carl Hull 196,078,626---- 31,324,5549,528,759 86%Elected—
Elect Director: Constantine Mihas 191,415,297---- 35,987,8839,528,759 84%Elected—
2. Proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024 236,288,478268,742374,720 ---- 99.9%Approved—
3. Proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting 223,303,6544,747,004200,454 --8,680,827 98%Approved—

Source: MARAVAI LIFESCIENCES HOLDINGS INC., Form 8-K, filed with the SEC on May 28, 2024 — read the filing on EDGAR.

How asset managers voted at the MARAVAI LIFESCIENCES HOLDINGS INC. 2023-2024 meeting

232 asset managers disclosed a vote on at least one MARAVAI LIFESCIENCES HOLDINGS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Benjamin Daverman

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD
FOR: 193,739,240WITHHELD: 33,663,940
Details: description as filed, official tally, votes by 65 asset managers

Description as filed by funds: To elect four nominees to the Board of Directors (3-year term expiring in 2027): Benjamin Daverman

MARAVAI LIFESCIENCES HOLDINGS INC.’s own tally for this item (“Elect Director: Benjamin Daverman”): 193,739,240 for, 33,663,940 withheld, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following nominees for director to serve for three-year terms expiring at the Company's 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, or until his or her earlier death, resignation or removal.”
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 22,545,130 for, 10,271,675 withheld.

FORWITHHOLD
FOR: 22,545,130WITHHOLD: 10,271,675
Largest asset managers voting on “To elect four nominees to the Board of Directors (3-year term expiring in 2027): Benjamin Daverman” at MARAVAI LIFESCIENCES HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,880,9240 033,800For
MFS00 03,103,299Withhold
Columbia Threadneedle2,532,8880 00For
Fidelity2,271,6680 0248,456Mixed
First Trust00 02,379,617Withhold
BlackRock2,081,0750 00For
GLENMEDE FUND INC00 02,056,654Withhold
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)1,629,6760 00For
Charles Schwab641,9290 00For
Dimensional00 0582,149Withhold
Legg Mason555,0370 00For
Invesco536,1380 00For
BUFFALO FUNDS512,4400 00For
WANGER ADVISORS TRUST480,0560 00For
Jackson National344,7170 027,413Mixed
Bridge Builder Trust19,3890 0317,212Mixed
TIAA00 0236,273Withhold
State Street240 0212,637Withhold
Transamerica193,8000 00For
Thrivent00 0172,933Withhold
Guardian Variable Products Trust142,4000 026,183Mixed
SEI120,0530 00For
JPMorgan108,0710 00For
AIG/SunAmerica00 0104,583Withhold
Russell Investments100,8070 00For

Showing the 25 largest of 65 asset managers. All 65 are in the interactive database (link above).

Elect Director: Susannah Gray

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD
FOR: 193,773,793WITHHELD: 33,629,387
Details: description as filed, official tally, votes by 65 asset managers

Description as filed by funds: To elect four nominees to the Board of Directors (3-year term expiring in 2027): Susannah Gray

MARAVAI LIFESCIENCES HOLDINGS INC.’s own tally for this item (“Elect Director: Susannah Gray”): 193,773,793 for, 33,629,387 withheld, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following nominees for director to serve for three-year terms expiring at the Company's 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, or until his or her earlier death, resignation or removal.”
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 22,524,879 for, 10,291,926 withheld.

FORWITHHOLD
FOR: 22,524,879WITHHOLD: 10,291,926
Largest asset managers voting on “To elect four nominees to the Board of Directors (3-year term expiring in 2027): Susannah Gray” at MARAVAI LIFESCIENCES HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,880,9240 033,800For
MFS00 03,103,299Withhold
Columbia Threadneedle2,532,8880 00For
Fidelity2,271,6680 0248,456Mixed
First Trust00 02,379,617Withhold
BlackRock2,081,0750 00For
GLENMEDE FUND INC00 02,056,654Withhold
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)1,629,6760 00For
Charles Schwab641,9290 00For
Dimensional00 0582,149Withhold
Legg Mason555,0370 00For
Invesco536,1380 00For
BUFFALO FUNDS512,4400 00For
WANGER ADVISORS TRUST480,0560 00For
Jackson National344,7170 027,413Mixed
Bridge Builder Trust19,3890 0317,212Mixed
TIAA00 0236,273Withhold
State Street240 0212,637Withhold
Transamerica193,8000 00For
Thrivent00 0172,933Withhold
Guardian Variable Products Trust142,4000 026,183Mixed
SEI120,0530 00For
JPMorgan108,0710 00For
AIG/SunAmerica00 0104,583Withhold
Russell Investments100,8070 00For

Showing the 25 largest of 65 asset managers. All 65 are in the interactive database (link above).

Elect Director: Carl Hull

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%
FOR: 196,078,626WITHHELD: 31,324,554
Details: description as filed, official tally, votes by 65 asset managers

Description as filed by funds: To elect four nominees to the Board of Directors (3-year term expiring in 2027): Carl Hull

MARAVAI LIFESCIENCES HOLDINGS INC.’s own tally for this item (“Elect Director: Carl Hull”): 196,078,626 for, 31,324,554 withheld, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following nominees for director to serve for three-year terms expiring at the Company's 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, or until his or her earlier death, resignation or removal.”
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 26,385,517 for, 6,431,288 withheld.

FORWITHHOLD
FOR: 26,385,517WITHHOLD: 6,431,288
Largest asset managers voting on “To elect four nominees to the Board of Directors (3-year term expiring in 2027): Carl Hull” at MARAVAI LIFESCIENCES HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,880,9240 033,800For
MFS3,103,2990 00For
Columbia Threadneedle2,532,8880 00For
Fidelity2,271,6680 0248,456Mixed
First Trust00 02,379,617Withhold
BlackRock2,081,0750 00For
GLENMEDE FUND INC00 02,056,654Withhold
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)1,629,6760 00For
Charles Schwab641,9290 00For
Dimensional00 0582,149Withhold
Legg Mason555,0370 00For
Invesco536,1380 00For
BUFFALO FUNDS512,4400 00For
WANGER ADVISORS TRUST480,0560 00For
Jackson National344,7170 027,413Mixed
Bridge Builder Trust336,6010 00For
TIAA236,2730 00For
State Street240 0212,637Withhold
Transamerica193,8000 00For
Thrivent00 0172,933Withhold
Guardian Variable Products Trust168,5830 00For
SEI120,0530 00For
JPMorgan108,0710 00For
AIG/SunAmerica00 0104,583Withhold
Russell Investments100,8070 00For

Showing the 25 largest of 65 asset managers. All 65 are in the interactive database (link above).

Elect Director: Constantine Mihas

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%WITHHELD
FOR: 191,415,297WITHHELD: 35,987,883
Details: description as filed, official tally, votes by 65 asset managers

Description as filed by funds: To elect four nominees to the Board of Directors (3-year term expiring in 2027): Constantine Mihas

MARAVAI LIFESCIENCES HOLDINGS INC.’s own tally for this item (“Elect Director: Constantine Mihas”): 191,415,297 for, 35,987,883 withheld, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following nominees for director to serve for three-year terms expiring at the Company's 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, or until his or her earlier death, resignation or removal.”
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 20,487,423 for, 12,329,382 withheld.

FORWITHHOLD
FOR: 20,487,423WITHHOLD: 12,329,382
Largest asset managers voting on “To elect four nominees to the Board of Directors (3-year term expiring in 2027): Constantine Mihas” at MARAVAI LIFESCIENCES HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,880,9240 033,800For
MFS00 03,103,299Withhold
Columbia Threadneedle2,532,8880 00For
Fidelity2,271,6680 0248,456Mixed
First Trust00 02,379,617Withhold
BlackRock2,081,0750 00For
GLENMEDE FUND INC00 02,056,654Withhold
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)00 01,629,676Withhold
Charles Schwab641,9290 00For
Dimensional00 0582,149Withhold
Legg Mason555,0370 00For
Invesco536,1380 00For
BUFFALO FUNDS512,4400 00For
WANGER ADVISORS TRUST480,0560 00For
Jackson National00 0372,130Withhold
Bridge Builder Trust19,3890 0317,212Mixed
TIAA00 0236,273Withhold
State Street240 0212,637Withhold
Transamerica193,8000 00For
Thrivent00 0172,933Withhold
Guardian Variable Products Trust142,4000 026,183Mixed
SEI120,0530 00For
JPMorgan108,0710 00For
AIG/SunAmerica00 0104,583Withhold
Russell Investments100,8070 00For

Showing the 25 largest of 65 asset managers. All 65 are in the interactive database (link above).

Proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, as…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 11 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%
FOR: 223,303,654AGAINST: 4,747,004
Details: description as filed, official tally, votes by 229 asset managers

Description as filed by funds: To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers, and

MARAVAI LIFESCIENCES HOLDINGS INC.’s own tally for this item (“3. Proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting”): 223,303,654 for, 4,747,004 against — passed, per its Form 8-K filed May 28, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's shareholders approved, on a non-binding and advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 65 asset managers voting on “To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers, and” at MARAVAI LIFESCIENCES HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,914,7240 00For
MFS3,103,2990 00For
Columbia Threadneedle2,532,8880 00For
Fidelity2,520,1240 00For
First Trust2,379,6170 00For
BlackRock2,081,0750 00For
GLENMEDE FUND INC2,056,6540 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)1,629,6760 00For
Charles Schwab641,9290 00For
Dimensional582,1490 00For
Legg Mason555,0370 00For
Invesco536,1380 00For
BUFFALO FUNDS512,4400 00For
WANGER ADVISORS TRUST480,0560 00For
Jackson National372,1300 00For
Bridge Builder Trust336,6010 00For
TIAA236,2730 00For
State Street212,6592 00For
Transamerica193,8000 00For
Thrivent172,9330 00For
Guardian Variable Products Trust168,5830 00For
SEI120,0530 00For
JPMorgan108,0710 00For
AIG/SunAmerica104,5830 00For
Russell Investments100,8070 00For

Fund voting reports, all 65 managers: 32,814,843 for, 2 against, 1,960 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 185 asset managers voting on “To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers, and” at MARAVAI LIFESCIENCES HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BRAIDWELL LP5,567,9510 00For
MACKENZIE FINANCIAL CORP5,016,3160 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/4,054,0900 00For
BlackRock3,606,3790 00For
Point723,604,9250 00For
Renaissance2,485,3220 00For
BAMCO INC /NY/1,974,3930 00For
MARSHALL WACE, LLP01,858,692 00Against
GEODE CAPITAL MANAGEMENT, LLC1,823,4510 00For
State Street1,723,96736,516 00For
Alyeska Investment Group, L.P.1,139,2820 00For
Granite Investment Partners, LLC1,021,5100 00For
Two Sigma956,0860 00For
AQR935,0950 00For
Northern Trust920,8815,477 00For
SYSTEMATIC FINANCIAL MANAGEMENT LP653,695127,920 00Mixed
DE Shaw724,9570 00For
Clearbridge Investments, LLC716,5190 00For
Charles Schwab641,9600 00For
Invesco616,7900 00For
Fidelity552,9100 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC0501,177 00Against
Portolan Capital Management, LLC422,8500 00For
Hudson Bay Capital Management LP373,4170 00For
Alpine Peaks Capital, LP0372,900 00Against

Institutional-manager reports, all 185 managers: 45,605,120 for, 3,635,945 against, 9 withheld, 174,231 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 236,288,478AGAINST: 268,742
Details: description as filed, official tally, votes by 65 asset managers

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as Maravai's independent registered public accounting firm for the year ending December 31, 2024;

MARAVAI LIFESCIENCES HOLDINGS INC.’s own tally for this item (“2. Proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024”): 236,288,478 for, 268,742 against — passed, per its Form 8-K filed May 28, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024 was ratified by the Company's shareholders.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 32,814,843 for, 2 against, 1,960 abstained.

FOR
FOR: 32,814,843AGAINST: 2ABSTAIN: 1,960
Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as Maravai's independent registered public accounting firm for ” at MARAVAI LIFESCIENCES HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,914,7240 00For
MFS3,103,2990 00For
Columbia Threadneedle2,532,8880 00For
Fidelity2,520,1240 00For
First Trust2,379,6170 00For
BlackRock2,081,0750 00For
GLENMEDE FUND INC2,056,6540 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)1,629,6760 00For
Charles Schwab641,9290 00For
Dimensional582,1490 00For
Legg Mason555,0370 00For
Invesco536,1380 00For
BUFFALO FUNDS512,4400 00For
WANGER ADVISORS TRUST480,0560 00For
Jackson National372,1300 00For
Bridge Builder Trust336,6010 00For
TIAA236,2730 00For
State Street212,6592 00For
Transamerica193,8000 00For
Thrivent172,9330 00For
Guardian Variable Products Trust168,5830 00For
SEI120,0530 00For
JPMorgan108,0710 00For
AIG/SunAmerica104,5830 00For
Russell Investments100,8070 00For

Showing the 25 largest of 65 asset managers. All 65 are in the interactive database (link above).

Largest MARAVAI LIFESCIENCES HOLDINGS INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 132,333,000 shares outstanding at the time of that meeting.

Fund voting reports: top MARAVAI LIFESCIENCES HOLDINGS INC. shareholders by shares voted on “To approve, on a non-binding advisory basis, the compensation of Maravai's named executive…”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 7.49%
2MFS 2.35%
3Columbia Threadneedle 1.91%
4Fidelity 1.90%
5First Trust 1.80%
6BlackRock 1.57%
7GLENMEDE FUND INC 1.55%
8BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) 1.23%
9Charles Schwab 0.49%
10Dimensional 0.44%
Institutional-manager reports: top MARAVAI LIFESCIENCES HOLDINGS INC. shareholders by shares voted on “To approve, on a non-binding advisory basis, the compensation of Maravai's named executive…”, 2023-2024
#Asset manager % of shares outstanding
1BRAIDWELL LP 4.21%
2MACKENZIE FINANCIAL CORP 3.79%
3MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 3.06%
4BlackRock 2.73%
5Point72 2.72%
6Renaissance 1.88%
7BAMCO INC /NY/ 1.49%
8MARSHALL WACE, LLP 1.40%
9GEODE CAPITAL MANAGEMENT, LLC 1.38%
10State Street 1.33%

Reported MARAVAI LIFESCIENCES HOLDINGS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

MARAVAI LIFESCIENCES HOLDINGS INC. holdings and ownership disclosed for the 2023-2024 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
GTCR21,681,033 16.38%Proxy statement (DEF 14A), proxy filed April 25, 2024
Maravai Life Sciences Holdings, LLC20,150,005 15.23%Schedule 13G, filed November 13, 2024
West Capital Management LP11,602,988 8.77%Proxy statement (DEF 14A), proxy filed April 25, 2024
BlackRock9,103,866 6.88%Form 13F, quarter ended March 31, 2024
Vanguard Group7,125,498 5.38%Form 13F, quarter ended March 31, 2024
Renaissance Technologies3,212,889 2.43%Form 13F, quarter ended March 31, 2024
Morgan Stanley2,883,767 2.18%Form 13F, quarter ended March 31, 2024
State Street2,036,274 1.54%Form 13F, quarter ended March 31, 2024
Geode Capital1,827,912 1.38%Form 13F, quarter ended March 31, 2024
D.E. Shaw1,603,236 1.21%Form 13F, quarter ended March 31, 2024

Percentages above are of 132,333,000 shares outstanding, as reported by MARAVAI LIFESCIENCES HOLDINGS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At MARAVAI LIFESCIENCES HOLDINGS INC.'s shareholder meeting held May 23, 2024, in the 2023-2024 proxy season, 232 asset managers reported votes on at least one of its 6 ballot items in their SEC Form N-PX filings, covering 1,514 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the compensation of Maravai's named executive… — MARAVAI LIFESCIENCES HOLDINGS INC.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: MARAVAI LIFESCIENCES HOLDINGS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 28, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from MARAVAI LIFESCIENCES HOLDINGS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

MARAVAI LIFESCIENCES HOLDINGS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Cite this page

Proxy Votes Now, “MARAVAI LIFESCIENCES HOLDINGS (MRVI) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/maravai-lifesciences-holdings-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.